National Institute of Allergy and Infectious Diseases
The National Institute of Allergy and Infectious Diseases (NIAID) is an American government agency underneath the National Institutes of Health, which itself operates under the United States Department of Health and Human Services (HHS).
Organization
Intellectual property
NIAID holds patent rights to a modified version of the SARS-CoV-2 spike protein, which have been licensed for use in currently available COVID-19 vaccines including mRNA-1273 and BNT162b2.1) The associated patents are:2) 3)
- 62/972,886
- PCT/US2021/017709
- US Application 17/798,021
The inventors listed on these patents within NIAID are financial beneficiaries of their use, presenting a conflict of interest between NIAID and pharmaceutical companies including Moderna and Pfizer.4)
In May 2022, NIAID licensed various COVID-19-related technologies to the World Health Organization's COVID-19 Technology Access Pool (C-TAP).5) 6)